Indrayani Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/08/2025 ,inter alia, to consider and approve INDRAYANI BIOTECH LTD.has ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indrayani Biotech has informed BSE that its Board will meet on August 30, 2025, to consider multiple key items. The most notable agenda is the proposed disinvestment from its material subsidiary, Dindigul Farm Product Limited, along with reclassifying the company's status there from 'Promoter' to 'Public shareholder.' The Board will also consider increasing the authorized share capital from Rs. 65 crores to Rs. 85 crores (8.50 crore equity shares of Rs. 10 each) and rescind a previous AGM resolution on a prior capital hike. Additionally, three Whole-Time Directors and one Independent Director are proposed to be appointed, and the notice for the 33rd Annual General Meeting will be approved.
The exit from the material subsidiary is a notable structural change that could simplify the company but may raise questions about its strategic direction. The proposed capital increase gives the company room to raise fresh funds later, which shareholders should watch closely.